Rayont Inc appoints Mrs. Leilani Latimer as Non-Executive Director to further enhance its Corporate Governance.
22 Avril 2021 - 3:00PM
Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an
international healthcare company specializing in the manufacturing
of alternative medicine products and services across the entire
value chain, today announces the appointment of Mrs. Leilani
Latimer as Non-Executive Director of Rayont Inc.
“We are pleased with the appointment of Mrs. Latimer. As the new
board director, she brings long experience in growing and scaling
businesses in Silicon Valley and globally. Her skills and
experience will help the business expansion of Rayont to become a
world-class healthcare company.” said Mr. Reyad Fezzani, Chairman
of the Board of Directors of Rayont Inc.
Leilani Latimer – Non-Executive Director
Leilani Latimer is a go-to-market executive and board director
with a track record of growing B2B, SaaS, enterprise software
companies - public, pre-IPO and start-ups. Ms. Latimer is currently
an Independent Director at Black Diamond Group (TSE: BDI) and a
Growth Advisor at WellKom International. Her board experience
includes participation on Executive, Nominating and Governance
committees, and she has held numerous Board Advisory roles with
Silicon Valley-based and global start-ups, as well as the
Chairmanship of a national non-profit organization.
Mrs. Latimer is the Chief Commercial & Marketing Officer at
Fair Trade USA, a global certification organization that drives
supply chain transparency and resiliency, while driving sustainable
development and poverty alleviation through "conscious capitalism".
She leads the organization’s commercial transformation efforts and
all marketing and commercial functions.
Previously, Mrs. Latimer was the Chief Marketing &
Commercial Operations Officer at Earlens, a privately held medical
technology company. Prior to Earlens, she led Global Marketing,
Partnerships & Commercial Operations for Zephyr Health, a
cloud-based data and analytics company (SaaS) serving the life
sciences industry. Mrs. Latimer’s deep technology experience in B2B
SaaS and marketplace technology includes 25 years with Sabre Inc.
(NASDAQ:SABR), the world’s largest technology and services provider
for the travel industry.
Mrs. Latimer holds a BA from UC San Diego, a certificate in
Management for International Executives from UC Riverside and a
certificate in Sustainable Management from Presidio Graduate
School. She resides in San Francisco, is a regular writer and
speaker, participates as an active member of the Silicon Valley
Italian Community, and holds both US and Italian citizenship.
About Rayont Inc.
Rayont, Inc. (RAYT) is a public traded company incorporated in
Nevada, USA since its inception in 2011. In 2018, the Company
repositioned itself to focus on healthcare including the
manufacturing of alternative medicine products and services across
the entire value chain.
Longer term, it has also invested in a groundbreaking cancer
treatment technology through an exclusive license arrangement for
the Sub-Saharan African territories.
Headquartered in Australia with expanding operations
internationally, Rayont`s purpose is “Making Natural
Products to Improve People`s Health”. We do this by
investing in early research and development, establishing high
quality manufacturing assets for regional distribution and
operating across the alternative medicine value chain.
Our underlying strategy is to grow organically, selectively
acquire, scale profitable assets and improve efficiency through
digitalization.
For further information, please visit www.rayont.com
SAFE HARBOR
Certain statements in this news release may
contain forward-looking information within the meaning of Rule 175
under the Securities Act of 1933, are subject to Rule 3b-6 under
the Securities Exchange Act of 1934, and are subject to the safe
harbors created by those rules. All statements, other than
statements of fact, included in this release, including, without
limitation, statements regarding potential future plans and
objectives of the company, are forward-looking statements that
involve risks and uncertainties. There can be no assurance that
such statements will prove to be accurate and other results and
further events could differ materially from those anticipated in
such statements. Future events and actual results could differ
materially from those set forth in, contemplated by, or underlying
the forward-looking statements.
Company Contact: Investor Relations
ir@rayont.com
- Leilani Latimer – Non-Executive Director
Sabre (NASDAQ:SABR)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Sabre (NASDAQ:SABR)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024